Postpartum Surgical Complications in Women with Inflammatory Bowel Disease After Caesarian Section: A Danish Nationwide Cohort Study

Article Gastroenterology & Hepatology

Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life

Shannon Linda Kanis et al.

Summary: This study aimed to describe the long-term health outcomes of children born to mothers with inflammatory bowel disease (IBD) and assess the impact of maternal IBD medication use on these outcomes. The results showed no association between in utero exposure to anti-TNF-alpha and/or thiopurine and long-term health outcomes, but an increased rate of intrahepatic cholestasis of pregnancy (ICP) was found when thiopurine was used during pregnancy.

GUT (2021)

Add to Collection

Article Gastroenterology & Hepatology

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

Uma Mahadevan et al.

Summary: The study found that exposure to biologic, thiopurine, or combination therapy during pregnancy did not increase adverse maternal or fetal outcomes, and these treatments can be continued throughout pregnancy for women with IBD to maintain disease control.

GASTROENTEROLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Maternal and Perinatal Outcome of Maternal Obesity at RSCM in 2014-2019

Junita Indarti et al.

Summary: Obesity is a global issue with a high prevalence in pregnant women, leading to various maternal and perinatal complications. While there are differences between obesity grades in terms of specific complications, overall prevalence rates do not significantly differ between different obesity grades.

OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2021)

Add to Collection

Article Gastroenterology & Hepatology